Recent advances in personalized pain medicine and clinical implications

Professor Ralf Baron presents a new therapeutic approach to neuropathic pain, based on assessment of the individual patient’s pain profile.

Professor Baron is/was a consultant for Pfizer Pharma GmbH, Genzyme GmbH, Grünenthal GmbH, Mundipharma Research GmbH & Co. KG, Allergan, Sanofi Pasteur, Medtronic, Eisai, Lilly GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Astellas Pharma GmbH, Novartis Pharma GmbH, Bristol-Myers Squibb, Biogenidec, AstraZeneca GmbH, Merck, Abbvie, Daiichi Sankyo, Glenmark Pharmaceuticals S.A., Seqirus Australia Pty. Ltd., Teva Pharmaceuticals Europe Niederlande, Teva GmbH, Genentech, Mundipharma International Ltd. UK, Astellas Pharma Ltd. UK, Galapagos NV, Kyowa Kirin GmbH, Vertex Pharmaceuticals Inc., Biotest AG, Celgene GmbH, Desitin Arzneimittel GmbH, Regeneron Pharmaceuticals Inc. USA, Theranexus DSV CEA Frankreich, Abbott Products Operations AG Schweiz, Bayer AG, Grunenthal Pharma AG Schweiz, Mundipharma Research Ltd. UK, Akcea Therapeutics Germany GmbH, Asahi Kasei Pharma Corporation, AbbVie Deutschland GmbH & Co. KG, Air Liquide Sante International Frankreich, Alnylam Germany GmbH, Lateral Pharma Pty Ltd, Hexal AG, AnQelini, Janssen, SIMR Biotech Pty Ltd Australie. He is/was a grant recipient/research support for EU Projects: ,,Europain" (115007). DOLORisk (633491 ). IMI Paincare (777500). German Federal Ministry of Education and Research (BMBF): Verbundprojekt: Fruhdetektion van Schmerzchronifizierung (NoChro) (13GW0338C).
German Research Network on Neuropathic Pain (01 EM0903). Pfizer Pharma GmbH, Genzyme GmbH, Grunenthal GmbH, Mundipharma Research GmbH und Co. KG., Novartis Pharma GmbH, Alnylam Pharmaceuticals Inc., Zambon GmbH. He is/was a speaker for Pfizer Pharma GmbH, Genzyme GmbH, Grunenthal GmbH, Mundipharma, Sanofi Pasteur, Medtronic Inc. Neuromodulation, Eisai Co.Ltd., Lilly GmbH, Boehringer lngelheim Pharma GmbH & Co. KG, Astellas Pharma GmbH, Desitin Arzneimittel GmbH, Teva GmbH, Bayer-Schering, MSD GmbH, Seqirus Australia Pty. Ltd, Novartis Pharma GmbH, TAD Pharma GmbH, Grunenthal SA Portugal, Sanofi­Aventis Deutschland GmbH, Agentur Brigitte Suss, Grunenthal Pharma AG Schweiz, Grunenthal B.V. Niederlande, Evapharma, Takeda Pharmaceuticals International AG Schweiz.